HALO logo
halo search icon
600062
China Resources Double-Crane Pharmaceutical Co., Ltd. Class A

600062 · China Resources Double-Crane Pharmaceutical Co., Ltd. Class A

16.63

CNY
-0.48 (-2.805%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Yuan17.77B

PE

11.40

EV/EBITDA

7.5

DIV Yield

2.6%

Payout Ratio

30%

MQV Rating

2Strong

As at 24/07/2026 12:00:00 AM

Price Chart

Description

China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the processing, manufacture, and sale of pharmaceutical, chemical, and biomedical raw materials. It operates through the following business segments: Infusion and Non-infusion. Its products include compound reserpine flattamine tablets, amlodipine besylate tablets, gliquidone tablets, citicoline sodium tablets, magnesium valproate sustained-release tablets, and soft bags. The company was founded on May 16, 1997 and is headquartered in Beijing, China.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • HALO All
  • HALO Price Momentum

Key Fundamentals

EPS 3 yr Growth

40.20%

EBITDA Margin

22.60%

Operating Cashflow

¥1,620m

Free Cash Flow Return

13.40%

ROIC

13.60%

Interest Coverage

71.20

Quick Ratio

1.80

Performance

52 weeks range

Low 15.29 - 22.14

Trade Value (12mth)

US$6,735,877.00

1 week

-2.23%

1 month

6.27%

YTD

-7.71%

1 year

-8.4%

All time high

37.44

Additional Data

Shares Outstanding (Fully Diluted)

1,039m

HALO Sector

Healthcare

Next Company Report Date

19-Mar-27

Next Ex Dividend Date

28-Jul-26

Next Dividend Pay Date

28-Jul-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Strong

Garp

Neutral

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
The current share price of China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is CNY¥16.63.
2
What is the 52-week high share price for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
The 52-week high share price for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is CNY¥22.14.
3
What is the 52-week low share price for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
The 52-week low share price for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is CNY¥15.29.
4
What is the dividend yield for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
The current TTM dividend payout for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is 2.60.
5
What was China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) last dividend payment?
Halo FAQ
The last dividend payment of China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is CNY¥0.10.
6
What is the franking level for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) has a franking level of 0.00%.
7
In which sector is China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) classified?
Halo FAQ
China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG)?
Halo FAQ
The current P/E ratio for China Resources Double-Crane Pharmaceutical Co., Ltd. Class A (600062:SHG) is 11.40.